Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
85.6M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
11.5K
-
Shares change
-
0
-
Total reported value, excl. options
-
$52.2K
-
Price
-
$4.55
Significant Holders of Larimar Therapeutics, Inc. - Common Stock (LRMR) as of Q4 2023
1 filings reported holding LRMR - Larimar Therapeutics, Inc. - Common Stock as of Q4 2023.
Larimar Therapeutics, Inc. - Common Stock (LRMR) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.5K shares
of 85.6M outstanding shares and own 0.01% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (16.9M shares), Blue Owl Capital Holdings LP (3.41M shares), Verition Fund Management LLC (2.81M shares), JANUS HENDERSON GROUP PLC (2.64M shares), BlackRock Inc. (1.67M shares), VANGUARD GROUP INC (1.46M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.28M shares), MANGROVE PARTNERS (806K shares), Woodline Partners LP (796K shares), and StemPoint Capital LP (783K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.